Gynura divaricata exerts hypoglycemic effects by regulating the PI3K/AKT signaling pathway and fatty acid metabolism signaling pathway

• Published in: Nutrition & diabetes 2020-08, Vol.10 (1), p.31-31, Article 31
• Main Authors: Xu, Wenjun, Lu, Zhongxia, Wang, Xin, Cheung, Man Hei, Lin, Meiai, Li, Changyu, Dong, Yu, Liang, Chun, Chen, Yitao
• Format: Article
• Language: English
• Subjects: 631/443/319/2723; 631/45/612/1191; 82/1; 82/80; Animals; Asteraceae - chemistry; Bioinformatics; Blood Glucose - analysis; Clinical Nutrition; Creatinine; Diabetes; Diabetes Mellitus, Experimental - drug therapy; Diabetes Mellitus, Experimental - metabolism; Diabetes Mellitus, Type 2 - drug therapy; Diabetes Mellitus, Type 2 - metabolism; Epidemiology; Fatty acids; Fatty Acids - metabolism; Hypoglycemia; Hypoglycemic Agents - chemistry; Hypoglycemic Agents - pharmacology; Insulin - metabolism; Insulin Resistance; Internal Medicine; Liver - metabolism; Male; Medicine; Medicine & Public Health; Metabolic Diseases; Metabolism; Phosphatidylinositol 3-Kinases - metabolism; Plant Extracts - chemistry; Plant Extracts - pharmacology; Proto-Oncogene Proteins c-akt - metabolism; Rats; Rats, Sprague-Dawley; Signal transduction; Signal Transduction - drug effects
• ISSN: 2044-4052; 2044-4052
• DOI: 10.1038/s41387-020-00134-z

Objectives The study aimed to examine the anti-diabetic effects of Gynura divaricata (GD) and the underlying mechanism. Methods Information about the chemical compositions of GD was obtained from extensive literature reports. Potential target genes were predicted using PharmMapper and analyzed using Kyoto Encyclopedia of Genes and Genomes (KEGG) and Gene Ontology (GO). To validate the results from bioinformatics analyses, an aqueous extract of GD was administered to type 2 diabetic rats established by feeding a high-fat and high-sugar diet followed by STZ injection. Key proteins of the PI3K/AKT signaling pathway and fatty acid metabolism signaling pathway were investigated by immunoblotting. Results The blood glucose of the rats in the GD treatment group was significantly reduced compared with the model group without treatment. GD also showed activities in reducing the levels of alanine aminotransferase (ALT), aspartate aminotransferase (AST), blood urea nitrogen (BUN), and creatinine (CREA). The levels of urine sugar (U-GLU) and urine creatinine (U-CREA) were also lowered after treatment with GD. Bioinformatics analysis showed that some pathways including metabolic pathways, insulin resistance, insulin signaling pathway, PPAR signaling pathway, bile secretion, purine metabolism, etc. may be regulated by GD. Furthermore, GD significantly increased the protein expression levels of PKM1/2, p-AKT, PI3K p85, and GLUT4 in the rat liver. In addition, the expression levels of key proteins in the fatty acid metabolism signaling pathway including AMPK, p-AMPK, PPARα, and CPT1α were significantly upregulated. The anti-apoptotic protein BCL-2/BAX expression ratio in rats was significantly upregulated after GD intervention. These results were consistent with the bioinformatics analysis results. Conclusions Our study suggests that GD can exert hypoglycemic effects in vivo by regulating the genes at the key nodes of the PI3K/AKT signaling pathway and fatty acid metabolism signaling pathway.